BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 12606947)

  • 1. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types.
    Majumdar S; Aggarwal BB
    Oncogene; 2003 Feb; 22(8):1206-18. PubMed ID: 12606947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester.
    Majumdar S; Lamothe B; Aggarwal BB
    J Immunol; 2002 Mar; 168(6):2644-51. PubMed ID: 11884428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation.
    Ashikawa K; Majumdar S; Banerjee S; Bharti AC; Shishodia S; Aggarwal BB
    J Immunol; 2002 Dec; 169(11):6490-7. PubMed ID: 12444159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
    Shishodia S; Koul D; Aggarwal BB
    J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 2000 Jun; 164(11):5815-25. PubMed ID: 10820260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
    Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
    J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
    Takada Y; Singh S; Aggarwal BB
    J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation.
    Majumdar S; Aggarwal BB
    J Immunol; 2001 Sep; 167(5):2911-20. PubMed ID: 11509639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
    Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
    Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
    Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
    Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Nov; 165(10):5962-9. PubMed ID: 11067959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression.
    Manna SK; Aggarwal BB
    J Immunol; 1999 Feb; 162(4):2095-102. PubMed ID: 9973483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression.
    Natarajan K; Manna SK; Chaturvedi MM; Aggarwal BB
    Arch Biochem Biophys; 1998 Apr; 352(1):59-70. PubMed ID: 9521814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9.
    Takada Y; Aggarwal BB
    J Immunol; 2003 Sep; 171(6):3278-86. PubMed ID: 12960358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.
    He KL; Ting AT
    Mol Cell Biol; 2002 Sep; 22(17):6034-45. PubMed ID: 12167698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents.
    Manna SK; Aggarwal BB
    J Immunol; 1998 Sep; 161(6):2873-80. PubMed ID: 9743348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calagualine inhibits nuclear transcription factors-kappaB activated by various inflammatory and tumor promoting agents.
    Manna SK; Bueso-Ramos C; Alvarado F; Aggarwal BB
    Cancer Lett; 2003 Feb; 190(2):171-82. PubMed ID: 12565172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.